- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 409047, 10 pages
Green Tea Attenuates Oxidative Stress and Downregulates the Expression of Angiotensin II AT1 Receptor in Renal and Hepatic Tissues of Streptozotocin-Induced Diabetic Rats
Department of Biological Sciences, Faculty of Science, Kuwait University, P.O. Box 5969, Safat 13060, Kuwait
Received 13 August 2012; Accepted 13 October 2012
Academic Editor: Khalid Rahman
Copyright © 2012 Martha Thomson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- J. H. Weisburger, “Tea and health: a historical perspective,” Cancer Letters, vol. 114, no. 1-2, pp. 315–317, 1997.
- N. Chen, R. Bezzina, E. Hinch et al., “Green tea, black tea, and epigallocatechin modify body composition, improve glucose tolerance, and differentially alter metabolic gene expression in rats fed a high-fat diet,” Nutrition Research, vol. 29, no. 11, pp. 784–793, 2009.
- J. M. Hodgson and K. D. Croft, “Tea flavonoids and cardiovascular health,” Molecular Aspects of Medicine, vol. 31, no. 6, pp. 495–502, 2010.
- Y. Clement, “Can green tea do that? A literature review of the clinical evidence,” Preventive Medicine, vol. 49, no. 2-3, pp. 83–87, 2009.
- S. M. Chacko, P. T. Thambi, R. Kuttan, and I. Nishigaki, “Beneficial effects of green tea: a literature review,” Chinese Medicine, vol. 5, article 13, 2010.
- Q. Guo, B. Zhao, M. Li, S. Shen, and X. Wenjuan, “Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes,” Biochimica et Biophysica Acta, vol. 1304, no. 3, pp. 210–222, 1996.
- H. Tsuneki, M. Ishizuka, M. Terasawa, J. B. Wu, T. Sasaoka, and I. Kimura, “Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans,” BMC Pharmacology, vol. 4, article 18, 2004.
- H. Iso, C. Date, K. Wakai et al., “The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults,” Annals of Internal Medicine, vol. 144, no. 8, pp. 554–562, 2006.
- S. Wolfram, D. Raederstorff, M. Preller et al., “Epigallocatechin gallate supplementation alleviates diabetes in rodents,” Journal of Nutrition, vol. 136, no. 10, pp. 2512–2518, 2006.
- International Diabetes Federation, IDF Diabetes Atlas, International Diabetes Federation, Brussels, Belgium, 5th edition, 2011, http://www.idf.org/diabetesatlas.
- D. Aronson, “Hyperglycemia and the pathobiology of diabetic complications,,” in Cardiovascular Diabetology: Clinical, Metabolic and Inflammatory Facets, E. Z. Fisman and A. Tenenbaum, Eds., Advances in Cardiology, Basel, Switzerland, 2008.
- American Diabetes Association, “Diagnosis and classification of diabetes mellitus,” Journal of Diabetes Care, vol. 33, supplement 1, pp. S62–S69, 2010.
- S. Tesfaye and G. Gill, “Chronic diabetic complications in Africa,” African Journal of Diabetes Medicine, vol. 9, pp. 4–8, 2011.
- Y. Xu, Z. He, and G. L. King, “Introduction of hyperglycemia and dyslipidemia in the pathogenesis of diabetic vascular complications,” Current Diabetes Reports, vol. 5, no. 2, pp. 91–97, 2005.
- A. P. Chintan, L. P. Nimish, B. Nayana, M. Bhavna, G. Mahendra, and T. Hardik, “Cardiovascular complication of diabetes mellitus,” Journal of Applied Pharmaceutical Science, vol. 4, pp. 1–6, 2011.
- A. C. Maritim, R. A. Sanders, and J. B. Watkins, “Diabetes, oxidative stress, and antioxidants: a review,” Journal of Biochemical and Molecular Toxicology, vol. 17, no. 1, pp. 24–38, 2003.
- R. Ahmed, “The physiological and biochemical effects of diabetes on the balance between oxidative stress and antioxidant defense system,” Medical Journal of Islamic World Academy of Sciences, vol. 15, pp. 31–42, 2005.
- P. Goycheva, V. Gadjeva, and B. Popov, “Oxidative stress and its complications in diabetes mellitus,” Trakia Journal of Sciences, vol. 4, pp. 1–8, 2006.
- V. Selvaraju, M. Joshi, S. Suresh, J. A. Sanchez, N. Maulik, and G. Maulik, “Diabetes, oxidative stress, molecular mechanism and cardiovascular disease—an overview,” Toxicology Mechanisms and Methods, vol. 22, no. 5, pp. 330–335, 2012.
- F. Locatelli, B. Canaud, K. U. Eckardt, P. Stenvinkel, C. Wanner, and C. Zoccali, “Oxidative stress in end-stage renal disease: an emerging treat to patient outcome,” Nephrology Dialysis Transplantation, vol. 18, no. 7, pp. 1272–1280, 2003.
- E. C. Samouilidou, E. J. Grapsa, I. Kakavas, A. Lagouranis, and B. Agrogiannis, “Oxidative stress markers and C-reactive protein in end-stage renal failure patients on dialysis,” International Urology and Nephrology, vol. 35, no. 3, pp. 393–397, 2003.
- E. Ritz, “Diabetic nephropathy,” Saudi Journal of Kidney Diseases and Transplantation, vol. 17, no. 4, pp. 481–490, 2006.
- S. C. W. Tang, “Diabetic nephropathy: a global and growing threat,” Hong Kong Medical Journal, vol. 16, no. 4, pp. 244–245, 2010.
- K. D. Burns, “Angiotensin II and its receptors in the diabetic kidney,” American Journal of Kidney Diseases, vol. 36, no. 3, pp. 449–467, 2000.
- C. Xue and H. M. Siragy, “Local renal aldosterone system and its regulation by salt, diabetes, and angiotensin II type 1 receptor,” Hypertension, vol. 46, no. 3, pp. 584–590, 2005.
- R. Bataller, P. Sancho-Bru, P. Ginès, and D. A. Brenner, “Liver fibrogenesis: a new role for the renin-angiotensin system,” Antioxidants and Redox Signaling, vol. 7, no. 9-10, pp. 1346–1355, 2005.
- H. M. Siragy, “AT1 and AT2 receptor in the kidney: role in health and disease,” Seminars in Nephrology, vol. 24, no. 2, pp. 93–100, 2004.
- L. Gnudi and D. Goldsmith, “Renin angiotensin aldosterone system (RAAS) inhibitors in the prevention of early renal disease in diabetes,” F1000 Medicine Reports, vol. 2, no. 1, article 18, 2010.
- National Research Counci, lInstitute for Laboratory Animal Research, and Commission on Life Sciences, Guide for the Care and Use of Animals, The National Academies Press, Washington, DC, USA, 1996.
- H. Drobiova, M. Thomson, K. Al-Qattan, R. Peltonen-Shalaby, Z. Al-Amin, and M. Ali, “Garlic increases antioxidant levels in diabetic and hypertensive rats determined by a modified peroxidase method,” Evidence-based Complementary and Alternative Medicine, vol. 2011, Article ID 703049, 8 pages, 2011.
- T. J. Murphy, R. W. Alexander, K. K. Griendling, M. S. Runge, and K. E. Bernstein, “Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor,” Nature, vol. 351, no. 6323, pp. 233–236, 1991.
- K. K. Al-Qattan, S. J. Al-Akhawand, and M. H. Mansour, “Immunohistochemical localization of distinct angiotensin II AT1 receptor isoforms in the kidneys of the Sprague-Dawley rat and the desert rodent Meriones Crassus,” Journal of Veterinary Medicine Series C, vol. 35, no. 2, pp. 130–138, 2006.
- M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976.
- H. Ohkawa, N. Ohishi, and K. Yagi, “Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction,” Analytical Biochemistry, vol. 95, no. 2, pp. 351–358, 1979.
- H. Abei, Catalase in the Method of Enzymatic Analysis, vol. 2, Academic Press, New York, NY, USA, 1974.
- Z. M. Al-Amin, M. Thomson, K. K. Al-Qattan, and M. Ali, “Anti-diabetic and hypolipidaemic properties of ginger (Zingiber officinale) in streptozotocin-induced diabetic rats,” British Journal of Nutrition, vol. 96, no. 4, pp. 660–666, 2006.
- M. Thomson, Z. M. Al-Amin, K. K. Al-Qattan, L. H. Shaban, and M. Ali, “Anti-diabetic and hypolipidaemic properties of garlic (Allium sativum) in streptozotocin-induced diabetic rats,” International Journal of Diabetes and Metabolism, vol. 15, no. 3, pp. 108–115, 2007.
- P. V. Anandh Babu, K. E. Sabitha, and C. S. Shyamaladevi, “Green tea extract impedes dyslipidaemia and development of cardiac dysfunction in streptozotocin-diabetic rats,” Clinical and Experimental Pharmacology and Physiology, vol. 33, no. 12, pp. 1184–1189, 2006.
- R. A. Anderson and M. M. Polansky, “Tea enhances insulin activity,” Journal of Agricultural and Food Chemistry, vol. 50, no. 24, pp. 7182–7186, 2002.
- L. Y. Wu, C. C. Juan, L. T. Ho, Y. P. Hsu, and L. S. Hwang, “Effect of green tea supplementation on insulin sensitivity in sprague-dawley rats,” Journal of Agricultural and Food Chemistry, vol. 52, no. 3, pp. 643–648, 2004.
- H. Ortsater, N. Grankvist, S. Wolfram, N. Kuehn, and A. Sjoholm, “Diet supplementation with green tea extract epigallocatechin gallate prevents progression to glucose intolerance in db/db mice,” Nutrition and Metabolism, vol. 9, pp. 11–17, 2012.
- L. Y. Wu, C. C. Juan, L. S. Hwang, Y. P. Hsu, P. H. Ho, and L. T. Ho, “Green tea supplementation ameliorates insulin resistance and increases glucose transporter IV content in a fructose-fed rat model,” European Journal of Nutrition, vol. 43, no. 2, pp. 116–124, 2004.
- Y. Kobayashi, M. Suzuki, H. Satsu et al., “Green tea polyphenols inhibit the sodium-dependent glucose transporter of intestinal epithelial cells by a competitive mechanism,” Journal of Agricultural and Food Chemistry, vol. 48, no. 11, pp. 5618–5623, 2000.
- K. Yasui, H. Tanabe, N. Okada, R. Fukutomi, Y. Ishigami, and M. Isemura, “Effects of catechin-rich green tea on gene expression of gluconeogenic enzymes in rat hepatoma H4IIE cells,” Biomedical Research, vol. 31, no. 3, pp. 183–189, 2010.
- T. Yokozawa, T. Nakagawa, and K. Kitani, “Antioxidative activity of green tea polyphenol in cholesterol-fed rats,” Journal of Agricultural and Food Chemistry, vol. 50, no. 12, pp. 3549–3552, 2002.
- O. O. Ojo, O. Ladeji, and M. S. Nadro, “Studies of the antioxidative effects of green and black tea (Camellia sinensis) extracts in rats,” Journal of Medicinal Food, vol. 10, no. 2, pp. 345–349, 2007.
- I. Hininger-Favier, R. Benaraba, S. Coves, R. A. Anderson, and A. M. Roussel, “Green tea extract decreases oxidative stress and improves insulin sensitivity in an animal model of insulin resistance, the fructose-fed rat,” Journal of the American College of Nutrition, vol. 28, no. 4, pp. 355–361, 2009.
- M. Roghani and T. Baluchnejadmojarad, “Hypoglycemic and hypolipidemic effect and antioxidant activity of chronic epigallocatechin-gallate in streptozotocin-diabetic rats,” Pathophysiology, vol. 17, no. 1, pp. 55–59, 2010.
- T. Yokozawa, T. Nakagawa, T. Oya, T. Okubo, and L. R. Juneja, “Green tea polyphenols and dietary fibre protect against kidney damage in rats with diabetic nephropathy,” Journal of Pharmacy and Pharmacology, vol. 57, no. 6, pp. 773–780, 2005.
- M. H. Mansour, K. Al-Qattan, M. Thomson, and M. Ali, “Garlic (Allium sativum) down-regulates the expression of angiotensin II AT1 receptor in adrenal and renal tissues of streptozotocin-induced diabetic rats,” Inflammopharmacology. In press.
- J. Zhuo, C. Maric, P. J. Harris, D. Alcorn, and F. A. O. Mendelsohn, “Localization and functional properties of angiotensin II AT1 receptors in the kidney: focus on renomedullary interstitial cells,” Hypertension Research, vol. 20, no. 4, pp. 233–250, 1997.
- A. A. Banday and M. F. Lokhandwala, “Oxidative stress-induced renal angiotensin AT1 receptor upregulation causes increased stimulation of sodium transporters and hypertension,” American Journal of Physiology, vol. 295, no. 3, pp. F698–F706, 2008.
- K. Sharma, Y. Jin, J. Guo, and F. N. Ziyadeh, “Neutralization of TGF-β by anti-TGF-β antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice,” Diabetes, vol. 45, no. 4, pp. 522–530, 1996.
- A. Elosta, T. Ghous, and N. Ahmed, “Natural products as anti-glycation agents: possible therapeutic potential for diabetic complications,” Current Diabetes Reviews, vol. 8, no. 2, pp. 92–108, 2012.
- J. E. Toblli, M. C. Mũoz, G. Cao, J. Mella, L. Pereyra, and R. Mastai, “ACE inhibition and AT1 receptor blockade prevent fatty liver and fibrosis in obese zucker rats,” Obesity, vol. 16, no. 4, pp. 770–776, 2008.